ICD-10 Coding for Acute Kidney Injury due to Immunotherapy(N14.1, N14.1N, N17.0U)
Learn about ICD-10 coding for acute kidney injury due to immunotherapy, including primary and ancillary codes, documentation requirements, and common pitfalls.
Complete code families applicable to Acute Kidney Injury due to Immunotherapy
Compare key differences between these codes to ensure accurate selection
| Code | Description | When to Use | Key Documentation |
|---|---|---|---|
| N17.9 | Acute kidney failure, unspecified | Use when AKI is linked to immunotherapy without specific histopathological findings. |
|
| N14.1 | Nephropathy induced by other drugs and biological substances | Use if documentation explicitly states drug-induced tubulointerstitial nephritis and guidelines support its use. |
|
Clinical Decision Support
Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.
Key Information
Essential facts and insights aboutAcute Kidney Injury due to Immunotherapy
Alternative codes to consider when ruling out similar conditions
Documentation & Coding Risks
Avoid these common issues when documenting Acute Kidney Injury due to Immunotherapy.
Vague documentation of AKI.
Impact
Clinical: May lead to inappropriate treatment decisions., Regulatory: Non-compliance with documentation standards., Financial: Potential for denied claims or reduced reimbursement.
Mitigation
Provide specific creatinine levels and timing., Link AKI to specific immunotherapy agent.
Using N14.1 without explicit ATIN documentation.
Impact
Reimbursement: Incorrect coding may lead to denied claims or reduced reimbursement., Compliance: Non-compliance with coding guidelines., Data Quality: Inaccurate clinical data reporting.
Mitigation
Default to N17.9 unless biopsy confirms drug-induced tubulointerstitial nephritis.
Omitting T45.1X5A.
Impact
Reimbursement: Potential loss of reimbursement for drug-related complications., Compliance: Failure to comply with coding standards for drug effects., Data Quality: Incomplete documentation of drug effects.
Mitigation
Always add adverse effect code for immunotherapy.
Documentation of Drug-Induced AKI
Impact
Inadequate documentation linking AKI to immunotherapy can trigger audits.
Mitigation
Ensure detailed documentation of creatinine changes and drug linkage.